(Q33379907)

26 July 2017

1 reference

title

Immunology and clinical importance of antiphospholipid antibodies (English)

1 reference

26 July 2017

Immunology and Clinical Importance of Antiphospholipid Antibodies (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

10 December 2022

1 reference

0 references

1

H. P. McNeil

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1853785

10 December 2022

author name string

C. N. Chesterman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1853785

10 December 2022

S. A. Krilis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1853785

10 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1853785

10 December 2022

publication date

1 January 1991

1 reference

26 July 2017

published in

Advances in Immunology

1 reference

26 July 2017

volume

49

1 reference

26 July 2017

page(s)

193-280

1 reference

The structural specificity of anti-phospholipid antibodies in autoimmune disease

26 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

10 December 2022

Lipid polymorphism

4

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lipid polymorphism and the roles of lipids in membranes

10 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Biologically false positive serologic tests for syphilis; type, incidence, and cause

10 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The natural history of systemic lupus erythematosus: An approach to its study through chronic biologic false positive reactors

10 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus erythematosus; serologic and chemical aspects

10 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Disseminate lupus erythematosus

10 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The occurrence of circulating anticoagulants in patients with syphilitic and biologically false positive antilipoidal antibodies

10 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

STUDIES ON THE SITE OF ACTION OF A CIRCULATING ANTICOAGULANT IN DISSEMINATED LUPUS ERYTHEMATOSUS. EVIDENCE THAT THIS ANTICOAGULANT INHIBITS THE REACTION BETWEEN ACTIVATED STUART FACTOR (FACTOR X) AND PROACCELERIN (FACTOR V)

10 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant

10 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

10 December 2022

Lupus anticoagulants

33

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant

10 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

10 December 2022

The lupus anticoagulant

36

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases

10 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

10 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Laboratory identification of the lupus anticoagulant

10 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure

10 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural Patterns

10 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Comparison of two simple tests for the lupus anticoagulant

10 December 2022

46

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The Varied Sensitivity of Partial Thromboplastin and Prothrombin Time Reagents in the Demonstration of the Lupus-Like Anticoagulant

10 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Comparison of laboratory tests used for identification of the lupus anticoagulant

10 December 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Clinical manifestations and laboratory findings in patients with lupus anticoagulants.

10 December 2022

50

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The sensitivity of different coagulation reagents to the presence of lupus anticoagulants

10 December 2022

51

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time

10 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon

10 December 2022

56

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The laboratory heterogeneity of lupus anticoagulants

10 December 2022

58

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Time dependency of lupuslike anticoagulants

10 December 2022

59

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The laboratory diagnosis of lupus anticoagulants

10 December 2022

60

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

10 December 2022

64

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

10 December 2022

66

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antiphospholipid antibodies

10 December 2022

68

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population

10 December 2022

70

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin response in acute infections

10 December 2022

71

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus

10 December 2022

72

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus

10 December 2022

73

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Crossreactivity of antiphospholipid antibodies

10 December 2022

78

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders

10 December 2022

79

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

10 December 2022

81

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Heat-labile serum inhibitor of anti-phospholipid antibody binding in ELISA

10 December 2022

86

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Influence of serum inactivation on detection of anticardiolipin antibodies (ACA) by ELISA

10 December 2022

87

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The demonstration of lupus anticoagulant by an enzyme-linked immunoadsorbent assay

10 December 2022

88

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Detection of antiphospholipid antibodies by ELISA-method with bovine thromboplastin as antigen

10 December 2022

90

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population

10 December 2022

92

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies

10 December 2022

93

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

10 December 2022

97

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus

10 December 2022

98

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus. Frequency and risk factors

10 December 2022

99

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA

10 December 2022

101

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Circulating anticoagulant in systemic lupus erythematosus: clinical manifestations

10 December 2022

103

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus.

10 December 2022

104

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

10 December 2022

105

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Profile and cross-reactivities of antiphospholipid antibodies in systemic lupus erythematosus and syphilis

10 December 2022

106

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant, thrombosis and thrombocytopenia in systemic lupus erythematosus.

10 December 2022

107

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients

10 December 2022

109

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies in patients with systemic lupus erythematosus.

10 December 2022

118

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies in patients with rheumatic diseases

10 December 2022

119

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients

10 December 2022

120

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus

10 December 2022

121

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibody and complement

10 December 2022

125

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant: a clinical and laboratory study of 100 cases

10 December 2022

126

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant: revival of an old phenomenon

10 December 2022

127

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody

10 December 2022

128

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies in autoimmune thrombocytopenic purpura

10 December 2022

129

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies: occurrence in Behçet's syndrome

10 December 2022

130

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

A collagen disorder of the nervous system presenting as multiple sclerosis.

10 December 2022

133

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies

10 December 2022

134

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Tetraplegia as a presenting feature of systemic lupus erythematosus complicated by pulmonary hypertension.

10 December 2022

135

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Transverse myelitis occurring during pregnancy in a patient with systemic lupus erythematosus

10 December 2022

136

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Connective tissue disease mimicking multiple sclerosis

10 December 2022

137

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

False-positive test result for IgM anticardiolipin antibody due to IgM rheumatoid factor

10 December 2022

139

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies in rheumatoid arthritis

10 December 2022

141

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity

10 December 2022

142

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations

10 December 2022

143

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Pregnancy outcome and autoantibodies in connective tissue disease

10 December 2022

144

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

ANTI-CARDIOLIPIN ANTIBODIES IN VIRAL INFECTION

10 December 2022

148

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies in lyme disease

10 December 2022

150

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Thrombosis in patients with the lupus anticoagulant

10 December 2022

153

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Circulating coagulation inhibitors in the acquired immunodeficiency syndrome

10 December 2022

157

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies associated with HTLV-III infection.

10 December 2022

158

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies in HIV infected patients with or without immune thrombocytopenic purpura

10 December 2022

159

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antiphospholipid antibodies in haemophiliacs

10 December 2022

160

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Effective inhibition of cardiolipin-binding antibodies in gram-negative infections by bacterial lipopolysaccharide

10 December 2022

166

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin response and its association with infections in young and middle-aged patients with cerebral infarction.

10 December 2022

167

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

10 December 2022

169

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

10 December 2022

170

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies

10 December 2022

173

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities

10 December 2022

174

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis

10 December 2022

175

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Risk factors for thrombosis in lupus patients

10 December 2022

182

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus

10 December 2022

185

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant in pregnancy

10 December 2022

192

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant and thrombosis in systemic lupus erythematosus

10 December 2022

193

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant in pregnancy

10 December 2022

194

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

"Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death

10 December 2022

197

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antibodies to phospholipids and nuclear antigens in patients with repeated abortions

10 December 2022

198

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anti-phospholipid antibody and pregnancy wastage

10 December 2022

199

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Spontaneous recurrent fetal wastage and autoimmune abnormalities: a study of fourteen cases

10 December 2022

200

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Autoimmunity, fetal losses, lupus anticoagulant: beginning of systemic lupus erythematosus or new autoimmune entity with gynaeco-obstetrical expression?

10 December 2022

201

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant in women with multiple spontaneous miscarriage

10 December 2022

203

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women

10 December 2022

204

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion

10 December 2022

205

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Subclinical autoimmunity in recurrent aborters

10 December 2022

209

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events

10 December 2022

211

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Coronary artery bypass graft failure--an autoimmune phenomenon?

10 December 2022

212

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies in ischaemic heart disease

10 December 2022

215

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Cerebral infarction associated with lupus anticoagulants--preliminary report

10 December 2022

216

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Phospholipid antibodies in cardiovascular disease

10 December 2022

218

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia

10 December 2022

219

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Syndrome of the black swan

10 December 2022

225

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antiphospholipid syndrome: linking many specialties

10 December 2022

226

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder

10 December 2022

227

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant

10 December 2022

230

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

'Lupus' anticoagulant and thrombosis of the hepatic veins (Budd-Chiari syndrome). Report of three patients and review of the literature

10 December 2022

231

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Cerebrovascular ischemia associated with lupus anticoagulant

10 December 2022

234

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Ischemic stroke associated with anticardiolipin antibodies

10 December 2022

235

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

10 December 2022

236

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia

10 December 2022

237

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies

10 December 2022

238

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Myocardial infarction and antiphospholipid antibodies in SLE and related disorders

10 December 2022

240

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Familial lupus anticoagulants

10 December 2022

243

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Familial occurrence of the antiphospholipid syndrome

10 December 2022

244

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Recurrent cerebral infarctions in two brothers with antiphospholipid antibodies that block coagulation reactions

10 December 2022

245

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus

10 December 2022

246

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Hla—dr antigens and anticardiolipin antibodies in northern italian systemic lupus erythematosus patients

10 December 2022

248

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

HLA-DR antigens and anticardiolipin antibodies

10 December 2022

249

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antiphospholipid antibodies--autoantibodies with a difference

10 December 2022

250

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal

10 December 2022

251

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Chorea gravidarum associated with circulating lupus anticoagulant: successful outcome of pregnancy with prednisone and aspirin therapy. Case report

10 December 2022

252

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Fetal survival after prednisone suppression of maternal lupus-anticoagulant

10 December 2022

253

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Obstetric complications associated with the lupus anticoagulant

10 December 2022

254

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant and pregnancy management

10 December 2022

255

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antiphospholipid antibodies in recurrent fetal loss: only one side of the coin?

10 December 2022

256

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Fetal loss treatment in patients with antiphospholipid antibodies.

10 December 2022

257

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment

10 December 2022

258

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Prophylactic low-dose aspirin and dipyridamole in pregnancy

10 December 2022

259

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Low-dose aspirin in pregnancy

10 December 2022

260

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization

10 December 2022

262

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Intravenous gamma-globulin, antiphospholipid antibodies, and pregnancy

10 December 2022

263

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lack of efficacy of plasma-exchange in removing antiphospholipid antibodies

10 December 2022

264

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone

10 December 2022

265

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant

10 December 2022

267

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus

10 December 2022

271

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies in systemic lupus erythematous

10 December 2022

272

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

10 December 2022

275

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Enzyme-linked immunosorbent assay for detection of antibodies to the venereal disease research laboratory (VDRL) antigen in syphilis

10 December 2022

276

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Immune reactivities of antibodies against glycolipids--I. Properties of anti-galactocerebroside antibodies purified by a novel technique of affinity binding to liposomes

10 December 2022

278

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation.

10 December 2022

282

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants

10 December 2022

284

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticoagulant activity of anticardiolipin antibodies

10 December 2022

285

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Purification of antiphospholipid antibodies using a new affinity method

10 December 2022

288

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column

10 December 2022

290

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

10 December 2022

291

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

10 December 2022

Anticardiolipin antibody

293

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Binding specificity of lupus anticoagulants and anticardiolipin antibodies

10 December 2022

295

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin antibodies and lupus anticoagulant

10 December 2022

296

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant

10 December 2022

297

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Pregnancy and autoimmunity

10 December 2022

298

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anti-phospholipid antibodies and pregnancy wastage

10 December 2022

299

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Association of lupus anticoagulant with antibody against phosphatidylserine

10 December 2022

300

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Polyfunctional properties of hybridoma lupus anticoagulant antibodies

10 December 2022

302

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Electron microscopic observations of lipid antigens with special reference to the Wassermann antigen

10 December 2022

306

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

STUDIES IN THE SEROLOGY OF SYPHILIS : VI. THE INDUCTION OF ANTIBODIES TO TISSUE LIPOIDS (A POSITIVE WASSERMANN REACTION) IN NORMAL RABBITS.

10 December 2022

307

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antibodies to liposomes, phospholipids and phosphate esters

10 December 2022

315

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Natural antibodies against tubulin, actin myoglobin, thyroglobulin, fetuin, albumin and transferrin are present in normal human sera, and monoclonal immunoglobulins from multiple myeloma and Waldenström's macroglobulinemia may express similar antibo

10 December 2022

317

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Murine natural monoclonal autoantibodies: a study of their polyspecificities and their affinities

10 December 2022

318

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Hypothesis. Auto-antibodies and immunological theories: An analytical review

10 December 2022

319

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids

10 December 2022

320

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Natural autoantibodies in systemic lupus erythematosus

10 December 2022

321

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antibodies to phospholipids and liposomes: binding of antibodies to cells

10 December 2022

323

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The phospholipid requirement for Rho(D) antigen activity: mode of inactivation by phospholipases and of protection by anti-Rh0(D) antibody

10 December 2022

324

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

10 December 2022

325

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

MECHANISM OF ACTION OF THE LUPUS ANTICOAGULANT

10 December 2022

327

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Monoclonal IgM with lupus anticoagulant activity in a case of Waldenström's macroglobulinaemia

10 December 2022

329

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Studies on Phospholipids in the Action of a Lupus Coagulation Inhibitor

10 December 2022

330

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

A DNA antigen that reacts with antisera to cardiolipin

10 December 2022

335

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids

10 December 2022

336

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Specificity of mouse hybridoma antibodies to DNA. II. Phospholipid reactivity and biological false positive serological test for syphilis

10 December 2022

337

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Monoclonal anti-cardiolipin antibodies bind to DNA

10 December 2022

338

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas

10 December 2022

340

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Evaluation of the cross-reaction between anti-DNA and anti-cardiolipin antibodies in SLE and experimental animals

10 December 2022

341

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity?

10 December 2022

342

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

New antibody in early syphilis

10 December 2022

343

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anti-mitochondrial type 5 antibodies and anti-cardiolipin antibodies in systemic lupus erythematosus and auto-immune diseases

10 December 2022

347

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Platelet antibodies in systemic lupus erythematosus

10 December 2022

351

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity

10 December 2022

353

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus

10 December 2022

354

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anti-endothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay

10 December 2022

356

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases

10 December 2022

359

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Reduced prostacyclin activity in systemic lupus erythematosus

10 December 2022

361

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation

10 December 2022

362

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

THROMBOTIC TENDENCY IN SYSTEMIC LUPUS ERYTHEMATOSUS

10 December 2022

363

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus anticoagulant, recurrent abortion, and prostacyclin production by cultured smooth muscle cells

10 December 2022

364

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Prostacyclin in systemic lupus and anticardiolipin syndrome

10 December 2022

366

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

The lupus anticoagulant stimulates the release of prostacyclin from human endothelial cells

10 December 2022

368

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels

10 December 2022

372

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity

10 December 2022

373

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant

10 December 2022

375

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis

10 December 2022

379

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients

10 December 2022

385

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Interaction between platelets and lupus anticoagulant

10 December 2022

386

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anticardiolipin and complement activation: relation to clinical symptoms

10 December 2022

387

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome

10 December 2022

388

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient

10 December 2022

389

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Anti-idiotypic antibodies against anti-phospholipid autoantibodies which suppress lupus-like anticoagulant activity

10 December 2022

391

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis

10 December 2022

392

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Antithrombin III in systemic lupus erythematosus

10 December 2022

393

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease

10 December 2022

395

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

10 December 2022

397

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation

10 December 2022

398

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease

10 December 2022

399

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I)

10 December 2022

400

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60777-4

10 December 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1853785

10 December 2022

1 reference